StockData
CollPlant Biotechnologies Ltd logo

CollPlant Biotechnologies Ltd (CLGN) income statement

CLGNNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31Also trades as OPHI
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 26, 2026Score 9/30
$3.96+0.06 (+1.54%)

Close on Nov 11, 2026Market cap $5.72MP/E –Yield –

CollPlant Biotechnologies Ltd income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY2025

Gross margin
64.8%
Operating margin
-484.3%
Net margin
-484.6%
Return on equity, FY2025
-117.6%

Financial strength

Current ratio
1.57
Debt to equity
–
Debt to assets
–
Cash to current liabilities
102.9%

Valuation

P/E ratio
–
Price to sales
2.41
Price to book
1.94
Dividend yield
–

See a number that looks wrong?